The disease management apps market size has grown rapidly in recent years. It will grow from $13.05 billion in 2025 to $14.75 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing smartphone penetration, growing adoption of digital health solutions, demand for continuous patient monitoring, expansion of telehealth services.
The disease management apps market size is expected to see rapid growth in the next few years. It will grow to $24.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to advancements in AI-based health analytics, integration of wearable health devices, increasing focus on preventive healthcare, growing acceptance of remote care models, rising healthcare cost optimization initiatives. Major trends in the forecast period include remote patient monitoring integration, personalized disease care pathways, medication adherence optimization, real-time health data analytics, wearable-enabled chronic care management.
The rising prevalence of chronic disorders is anticipated to drive the expansion of the disease management apps market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical conditions that last for an extended duration, generally three months or longer. Disease management apps are used in chronic care to offer tools for symptom tracking, medication logging, vital sign monitoring, and trigger identification. For instance, in June 2024, according to the National Health Service, a UK-based government body, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes) in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Thus, the growing burden of chronic conditions is contributing to the growth of the disease management apps market going forward.
Major companies operating in the disease management apps market are emphasizing technological innovations such as GenAI to enhance their profitability. GenAI is an artificial intelligence technology that automates the generation of clinical summary reports and improves communication between patients and healthcare providers. For example, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, introduced a GenAI-powered artificial intelligence (AI) disease management platform using Google Cloud. This advanced technology is specifically engineered to integrate into its disease management platform to strengthen decision-making tools for diagnostics, treatment, and recommendations.
In February 2023, Amazon.com Inc. acquired the One Medical app from 1Life Healthcare, Inc. for approximately $3.9 billion. This strategic move allows Amazon.com Inc. to expand its services, offering various disease management features such as remote visits, 24/7 on-demand virtual care services, and on-demand video chats through the One Medical app. 1Life Healthcare, Inc. is a virtual care provider of the disease management app One Medical based in the United States.
Major companies operating in the disease management apps market are Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
North America was the largest region in the disease management apps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease management apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disease management apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the disease management apps market by indirectly increasing development and deployment costs through higher prices for imported wearables, sensors, cloud infrastructure hardware, and supporting digital health devices. These impacts are most visible across wearable-integrated app segments and smartphone-based platforms, with regions such as Asia-Pacific and North America experiencing supply chain adjustments due to their reliance on global electronics manufacturing and software services. Tariff pressures have slowed device affordability in some end-user groups while pushing developers to optimize software-only solutions and cloud-based disease management platforms. On the positive side, tariffs have encouraged localized development, regional partnerships, and innovation in cost-efficient app architectures, strengthening long-term resilience within the disease management apps ecosystem.
The disease management apps market research report is one of a series of new reports that provides disease management apps market statistics, including disease management apps industry global market size, regional shares, competitors with a disease management apps market share, detailed disease management apps market segments, market trends and opportunities, and any further data you may need to thrive in the disease management apps industry. This disease management apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Disease management apps are software applications designed to assist individuals in monitoring, managing, and improving their health, particularly when dealing with chronic medical conditions or diseases. These apps incorporate various digital tools and wearables that enable healthcare professionals to remotely track patients' symptoms and activities and share information regarding medication adherence.
The main platform types for disease management apps include iOS, Android, and other platform types. iOS refers to a mobile operating system developed for Apple's mobile devices, including the iPhone, iPad, and iPod Touch. These apps are compatible with various devices such as smartphones, tablets, and wearables, and they are used for managing conditions such as obesity, cardiovascular issues, mental health, diabetes, and other medical indications.
The disease management apps market includes revenues earned by entities by provide disease management services such as medication management, health tracking, and e-prescribing software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The disease management apps market consists of sales of wearable devices such as sensors, remote patient monitoring devices, and fitness trackers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The disease management apps market size is expected to see rapid growth in the next few years. It will grow to $24.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to advancements in AI-based health analytics, integration of wearable health devices, increasing focus on preventive healthcare, growing acceptance of remote care models, rising healthcare cost optimization initiatives. Major trends in the forecast period include remote patient monitoring integration, personalized disease care pathways, medication adherence optimization, real-time health data analytics, wearable-enabled chronic care management.
The rising prevalence of chronic disorders is anticipated to drive the expansion of the disease management apps market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical conditions that last for an extended duration, generally three months or longer. Disease management apps are used in chronic care to offer tools for symptom tracking, medication logging, vital sign monitoring, and trigger identification. For instance, in June 2024, according to the National Health Service, a UK-based government body, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes) in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Thus, the growing burden of chronic conditions is contributing to the growth of the disease management apps market going forward.
Major companies operating in the disease management apps market are emphasizing technological innovations such as GenAI to enhance their profitability. GenAI is an artificial intelligence technology that automates the generation of clinical summary reports and improves communication between patients and healthcare providers. For example, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, introduced a GenAI-powered artificial intelligence (AI) disease management platform using Google Cloud. This advanced technology is specifically engineered to integrate into its disease management platform to strengthen decision-making tools for diagnostics, treatment, and recommendations.
In February 2023, Amazon.com Inc. acquired the One Medical app from 1Life Healthcare, Inc. for approximately $3.9 billion. This strategic move allows Amazon.com Inc. to expand its services, offering various disease management features such as remote visits, 24/7 on-demand virtual care services, and on-demand video chats through the One Medical app. 1Life Healthcare, Inc. is a virtual care provider of the disease management app One Medical based in the United States.
Major companies operating in the disease management apps market are Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
North America was the largest region in the disease management apps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease management apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the disease management apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the disease management apps market by indirectly increasing development and deployment costs through higher prices for imported wearables, sensors, cloud infrastructure hardware, and supporting digital health devices. These impacts are most visible across wearable-integrated app segments and smartphone-based platforms, with regions such as Asia-Pacific and North America experiencing supply chain adjustments due to their reliance on global electronics manufacturing and software services. Tariff pressures have slowed device affordability in some end-user groups while pushing developers to optimize software-only solutions and cloud-based disease management platforms. On the positive side, tariffs have encouraged localized development, regional partnerships, and innovation in cost-efficient app architectures, strengthening long-term resilience within the disease management apps ecosystem.
The disease management apps market research report is one of a series of new reports that provides disease management apps market statistics, including disease management apps industry global market size, regional shares, competitors with a disease management apps market share, detailed disease management apps market segments, market trends and opportunities, and any further data you may need to thrive in the disease management apps industry. This disease management apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Disease management apps are software applications designed to assist individuals in monitoring, managing, and improving their health, particularly when dealing with chronic medical conditions or diseases. These apps incorporate various digital tools and wearables that enable healthcare professionals to remotely track patients' symptoms and activities and share information regarding medication adherence.
The main platform types for disease management apps include iOS, Android, and other platform types. iOS refers to a mobile operating system developed for Apple's mobile devices, including the iPhone, iPad, and iPod Touch. These apps are compatible with various devices such as smartphones, tablets, and wearables, and they are used for managing conditions such as obesity, cardiovascular issues, mental health, diabetes, and other medical indications.
The disease management apps market includes revenues earned by entities by provide disease management services such as medication management, health tracking, and e-prescribing software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The disease management apps market consists of sales of wearable devices such as sensors, remote patient monitoring devices, and fitness trackers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Disease Management Apps Market Characteristics
3. Disease Management Apps Market Supply Chain Analysis
4. Global Disease Management Apps Market Trends and Strategies
5. Disease Management Apps Market Analysis of End Use Industries
7. Global Disease Management Apps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Disease Management Apps Total Addressable Market (TAM) Analysis for the Market
9. Disease Management Apps Market Segmentation
10. Disease Management Apps Market, Industry Metrics by Country
11. Disease Management Apps Market Regional and Country Analysis
12. Asia-Pacific Disease Management Apps Market
13. China Disease Management Apps Market
14. India Disease Management Apps Market
15. Japan Disease Management Apps Market
16. Australia Disease Management Apps Market
17. Indonesia Disease Management Apps Market
18. South Korea Disease Management Apps Market
19. Taiwan Disease Management Apps Market
20. South East Asia Disease Management Apps Market
21. Western Europe Disease Management Apps Market
22. UK Disease Management Apps Market
23. Germany Disease Management Apps Market
24. France Disease Management Apps Market
25. Italy Disease Management Apps Market
26. Spain Disease Management Apps Market
27. Eastern Europe Disease Management Apps Market
28. Russia Disease Management Apps Market
29. North America Disease Management Apps Market
30. USA Disease Management Apps Market
31. Canada Disease Management Apps Market
32. South America Disease Management Apps Market
33. Brazil Disease Management Apps Market
34. Middle East Disease Management Apps Market
35. Africa Disease Management Apps Market
37. Disease Management Apps Market Competitive Landscape and Company Profiles
38. Disease Management Apps Market Other Major and Innovative Companies
41. Disease Management Apps Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Disease Management Apps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses disease management apps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for disease management apps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease management apps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Platform Type: iOS; Android; Other Platform Types2) By Device: Smartphones; Tablets; Wearables
3) By Indication: Obesity; Cardiovascular Issues; Mental Health; Diabetes; Other Indications
Subsegments:
1) By iOS: IPhone Apps; iPad Apps2) By Android: Smartphone Apps; Tablet Apps
3) By Other Platform Types: Windows Mobile Apps; Web-Based Apps
Companies Mentioned: Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Disease Management Apps market report include:- Alphabet Inc.
- International Business Machines Corporation
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Garmin International Inc.
- DexCom Inc.
- Epic Systems Corporation
- Teladoc Inc.
- Fitbit LLC
- athenahealth Inc.
- Allscripts Healthcare Solutions Inc.
- Omada Health Inc.
- Calm.com Inc.
- Livongo Health Inc.
- American Well Corporation
- MyFitnessPal Inc.
- Talkspace Inc.
- Noom Inc.
- Ada Health GmbH
- Healthy.io Ltd.
- Medisafe International LLC
- Sleep Cycle AB
- Buoy Health Inc.
- Azumio Inc.
- Propeller Health Inc.
- Welldoc Inc.
- Informed Data Systems Inc.
- Curable Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.75 Billion |
| Forecasted Market Value ( USD | $ 24.18 Billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
